COMPUMEDICS LIMITED — Earnings Release 2018

Aug 29, 2018

==> picture [469 x 110] intentionally omitted <==

Company Announcement

Business Update: Appendix 4E Release

Thursday 30 August 2018

Correction - NPAT up 113% to $2.8 million

PERFORMANCE RESULTS FY18 - Correction

• Today’s announcement referred to NPAT as having increased 133% to $2.8m for FY18, compared to $1.3m for FY17. The correct percentage increase was 113%

Compumedics Limited (ASX: CMP) (“Compumedics” or “Company”) wishes to advice the percentage increase in NPAT over the prior corresponding period was 113%, not 133% as originally presented in this mornings Business Update.

About Compumedics Limited

Compumedics Limited [ASX: CMP] is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including the Americas, Australia and Asia Pacific, Europe and the Middle East.

Executive Chairman Dr David Burton founded Compumedics in 1987. In the same year the company successfully designed and installed the first Australian, fully computerised sleep clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets.

Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards, including Australia’s Exporter of the Year, and has been recognised as a Top 100 Innovator by both German and Australian governments.

==> picture [226 x 54] intentionally omitted <==

For further information please contact:

Dr David Burton

Executive Chairman, CEO Executive Director Phone: + 61 3 8420 7300 Fax: +61 3 8420 7399

David Lawson Chief Financial Officer Phone: + 61 3 8420 7300 Fax: +61 3 8420 7399

Investor Relations, Media & PR enquires:

Rod North Managing Director Bourse Communications Pty Ltd Phone: +61 3 9510 8309 Mobile: 0408 670 706

Richard Allen Oxygen Financial PR Ph: + 61 3 9915 6341 Mob: 0403 493 049